21 CFR 900.5
§ 900.5 Evaluation.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 900.5, § 900.5 Evaluation, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/91376
- Permanent ID
ys:prov:91376@1- SHA-256
8774577f729c41e47979a289b421f4728e63b836a896d0c2cebc2fc20b716e97
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
FDA shall evaluate annually the performance of each accreditation body. Such evaluation shall include an assessment of the reports of FDA or State inspections of facilities accredited by the body as well as any additional information deemed relevant by FDA that has been provided by the accreditation body or other sources or has been required by FDA as part of its oversight initiatives. The evaluation shall include a determination of whether there are major deficiencies in the accreditation body's performance that, if not corrected, would warrant withdrawal of the approval of the accreditation body under the provisions of § 900.6.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.